Growth hormone deficiency in children and adolescents with cerebral Palsy: Relation to gross motor function and degree of spasticity

Pakistan Journal of Biological Sciences

Volumn 14, Issue 7, 2011, Pages 433-440

  Hamza, Rasha T ^a   Ismail, Mona A ^a   Hamed, Amira I ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Cerebral palsy; Growth hormone deficiency; Insulin like growth factor binding protein 3; Insulin like growth factor 1; Short stature

Indexed keywords

HUMAN GROWTH HORMONE; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BLOOD; CASE CONTROL STUDY; CEREBRAL PALSY; CHILD; COMORBIDITY; FEMALE; GASTROINTESTINAL DISEASE; HEMIPLEGIA; HUMAN; MALE; MENTAL DISEASE; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PSYCHOMOTOR PERFORMANCE; QUADRIPLEGIA; SEIZURE; SPASTICITY;

ADOLESCENT; CASE-CONTROL STUDIES; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; GASTROINTESTINAL DISEASES; HEMIPLEGIA; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MENTAL DISORDERS; MUSCLE SPASTICITY; MUSCLE WEAKNESS; PSYCHOMOTOR PERFORMANCE; QUADRIPLEGIA; SEIZURES;

EID: 79960270560     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2011.433.440     Document Type: Article

References (42)

1. Aberg, M.A.I., N.D. Aberg, T.D. Palmer, A.M. Alborn and C. Carlsson-Skwirut et al., 2003. IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Mol. Cell. Neurosci., 24: 23-40.
2. Aberg, N.D., I. Johansson, M.A.I. Aberg, J. Lind and U.E. Johansson et al., 2009. Peripheral administration of GH induces cell proliferation in the brain of adult hypophysectomizedrats. J. Endocrinol., 201: 141-150.
3. Aberg, N.D., J. Lind, J. Isgaard and H.G. Kuhn, 2010. Peripheral growth hormone induces cell proliferation in the intact adult rat brain. Growth Horm. IGF Res., 20: 264-269.
4. Aberg, N.D., K.G. Brywe and J. Isgaard, 2006. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration and functional plasticity in the adult brain. Scientific World J., 6: 53-80.
5. Ali, O., M. Shim, E. Fowler, P. Cohen and W. Oppenheim, 2007. Spinal bone mineral density, IGF-1 andIGFBP-3 in children with cerebral palsy. Horm. Res., 68: 316-320.
6. Ballerini, M.G., M.G. Ropelato, H.M. Domene, P. Pennisi, J.J. Heinrichand, H.G. Jasper, 2004. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis. J. Pediatr. Endocrinol. Metab., 17: 749-757.
7. Bohannon, R.W. and M.B. Smith, 1987. Interrater reliability of a modified ashworth scale of muscle spasticity. Phys. Ther., 67: 206-207.
8. Bruel-Jungerman, E., A. Veyrac, F. Dufour, J. Horwood, S. Laroche and S. Davis, 2009. Inhibition of PI3K-Akt signaling blocks exercise-mediated enhancement of adult neurogenesis and synaptic plasticity in the dentate gyrus. PloS One, 4: e7901-e7901.
9. Cavlak, U. and E. Kavlak, 2005. Analysing of ankle-foot deformities in cerebral palsied children: A retrospective study. J. Medical Sci., 5: 55-60.
10. Chang, S. and P. Hui, 2011. Safety of recombinant human growth hormone in treating children with growth hormone deficiency and idiopathic short stature. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 33: 123-126.
11. Christophidis, L.J., T. Gorba, M. Gustavsson, C.E. Williams, G.A. Werther, V.C. Russo and A. Scheepens, 2009. Growth hormone receptor immunoreactivity is increased in the subventricular zone of juvenile rat brain after focal ischemia: A potential role for growth hormone in injury-induced neurogenesis. Growth Horm. IGF Res., 19: 497-506.
12. Chung, Y.H., CM. Shin, K.M. Joo, M.J. Kima and C.I. Cha, 2002. Region-specific alterations in insulin-like growth factor receptor type I in the cerebral cortex and hippocampus of aged rats. BramRes.,946: 307-313.
13. Cole, T.J., 2002. A chart to link child centiles of body mass index, weight and height. Eur. J. Clin. Nutr.,56: 1194-1199.
14. Coniglio, S.J. and R.D. Stevenson, 1995. Growth hormone deficiency in two children with cerebral palsy. Dev. Med. ChildNeurol., 37: 1013-1015.
15. Coniglio, S.J., R.D. Stevenson and A.D. Rogol, 1996. Apparent growth hormone deficiency in children with cerebral palsy. Dev. Med. Child Neurol., 38: 797-804.
16. Dietz, V., 1999. Supraspinal pathways and the development of muscle-tone dysregulation. Dev. Med. Child. Neurol, 41: 708-715.
17. Frystyk, J., D.J. Brick, A.V. Gerweck, A.L. Utz and K.K. Miller, 2009. Bioactive insulin-like growth factor-I in obesity. J. Clin. Endocrinol. Metab., 94: 3093-3097.
18. Gorassini, M.A., M.E. Knash, P.J. Harvey, D.J. Bennett and J.F. Yang, 2004. Role of motoneurons in the generation of muscle spasms after spinal cord injury. Bram, 127: 2247-2258.
19. Greenwood, F.C., J. Landon and T.C.B. Stamp, 1966. The plasma sugar, free fatty acid, Cortisol and growth hormone response to insulin I. In control subjects. J. Clin. Invest., 45: 429-436.
20. Gustafson, K., H. Hagberg, B.A. Bengtsson, C. Brantsing and J. Isgaard, 1999. Possible protective role of growth hormone in hypoxia-ischemia in neonatal rats. Pediatr. Res., 45: 318-323.
21. Hayashi, Y., T. Shiraishi, J. Tani, K. Araki and T. Kurashige, 1989. Pituitary reserve of growth hormone in adolescent patients with cerebral palsy and mental retardation. No To Hattatsu, 21: 239-244.
22. Henderson, R.C., P.P. Lin and W.B. Greene, 1995. Bone-mineral density in children and adolescents who have spastic cerebral palsy. J. Bone Joint Surg. Am., 77: 1671-1681.
23. Johannsson, G. and C. Ohlsson, 1998. Growth hormone therapy and fracture risk in the growth hormone-deficient adult. Baillieres Clin. Endocrinol. Metab., 12: 233-250.
24. Juul, A., P. Dalgaard, W.F. Blum, P. Bang and K. Hall, et at, 1995. Serum levels of insulin-like growth factor (IGF)-bmding protem-3 (IGFBP-3) in healthy infants, children and adolescents: the relation to IGF-I, IGF-n, IGFBP-1, IGFBP-2, age, sex, body mass index and pubertal maturation. J. Clin. Endocrinol. Metab., 80: 2534-2542.
25. Krageloh-Mann, I. and C. Cans, 2009. Cerebral palsy update. Brain Dev., 31: 537-544.
26. Krick, J., P. Murphy-Miller, S. Zeger and E. Wright 1996. Pattern of growth in children with cerebral palsy. J. Am. Diet Assoc., 96: 680-685.
27. Kruse, M., S.I. Michelsen, E.M. Flachs, H. Bronnum-Hansen, M. Madsenand, P. Uldall, 2009. Lifetime costs of cerebral palsy. Dev. Med. Child Neurol., 51: 622-628.
28. Kuperminc, M.N, M.J. Gurka, CM. Houlihan, R.C. Henderson, J.N. Roemmich, A.D. Rogol and R.D. Stevenson, 2009. Puberty, statural growth and growth hormone release in children with cerebral palsy. J. Pediatr. Rehabil. Med., 2: 131-141.
29. Mohammadian, S. and H. Khoddam, 2007. An etiologic evaluation of children with short stature in Gorgan (NortheastIran), 2005. J. Medical Sci., 7: 1206-1209.
30. Nia, K.M. and S. Salehi, 2008. Evaluation of changes in serum insulin-like growth factor-1 and insulin-like growth factor binding protein 3 in children with adenotonsillar hypertrophy before and after surgery. J. Medical Sci., 8: 148-151.
31. Nielsen, J.B., C. Crone andH. Hultborn, 2007. The spinal pathophysiology of spasticity: From a basic science point of view. Acta Physiol., 189: 171-180.
32. Nieves-Martinez, E., W.E. Sonntag, A. Wilson, A. Donahue, D.P. Molina, J. Brunso-Bechtold and M.M. Nicolle, 2010. Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation. J. Endocrinol, 204: 31-36.
33. Reimunde, P., C. Rodicio, N. Lopez, A. Alonso, P. Devesa and J. Devesa, 2010. Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy. Ther. Clin. Risk Manage., 6: 585-592.
34. Russell, D.J., L.M. Avery, P.L. Rosenbaum, P.S. Raina, S.D. Walter and R.J. Palisano, 2000. Improved scaling of the gross motor function measure for children with cerebral palsy: Evidence of reliability and validity. Phys. Ther., 80: 873-885.
35. Saxena, V. and N.S.H.N. Moorthy, 2007. Insulin like growth factor-1 receptor: An anticancer target waiting for hit. Int. J. Cancer Res., 3: 54-73.
36. Scacchi, M., A.I. Pincelli and F. Cavagnini, 2003. Nutritional status in the neuroendocrine control of growth hormone secretion: The model of anorexia nervosa. Front. Neuroendocrinol, 24: 200-224.
37. Shim, M.L., T. Moshang Jr., W.L. Oppenheim and P. Cohen, 2004. Is treatment with growth hormone effective in children with cerebral palsy? Dev. Med. Child Neurol, 46: 569-571.
38. Stevenson, R.D., R.P. Hayes, L.V. Cater and J.A. Blackman, 1994. Clinical correlates of linear growth in children with cerebral palsy. Dev. Med. ChildNeurol.,36: 135-142.
39. Tanner, J.M. and R.H. Whitehouse, 1976. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch. Dis. Child., 51: 170-179.
40. Teale, J.D and V. Marks, 1986. The measurement of insulin-like growth factor I: Clinical applications and significance. Ann. Clin. Biochem., 23: 413-424.
41. Wechsler, D., 1991. Wechsler Intelligence Scale for Children. 3rd Edn, The Psychological Corporation, San Antonio.
42. Ziadat, A.H., 2007. Effect of motor-rehabilitation training programme for children with cerebral palsy. J. Medical Sci., 7: 432-438.